These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


556 related items for PubMed ID: 6205440

  • 21. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
    Mero M, Tenhunen R, Pessi T, Sandholm M.
    Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
    [Abstract] [Full Text] [Related]

  • 22. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A, Ohlsson K.
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [Abstract] [Full Text] [Related]

  • 23. Studies on the plasma kallikrein-kinin system in peritoneal exudate and plasma during experimental acute pancreatitis in pigs.
    Ruud TE, Aasen AO, Kierulf P, Stadaas J, Aune S.
    Scand J Gastroenterol; 1985 Sep; 20(7):877-82. PubMed ID: 2413521
    [Abstract] [Full Text] [Related]

  • 24. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
    Geokas MC, Largman C, Durie PR, Brodrick JW, Ray SB, O'Rourke M, Vollmer J.
    Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
    Griesbacher T, Rainer I, Tiran B, Fink E, Lembeck F, Peskar BA.
    Br J Pharmacol; 2003 May; 139(2):299-308. PubMed ID: 12770935
    [Abstract] [Full Text] [Related]

  • 27. Proteinases and inhibitors in plasma and peritoneal exudate in acute pancreatitis.
    Wendt P, Fritsch A, Schulz F, Wunderlich G, Blümel G.
    Hepatogastroenterology; 1984 Dec; 31(6):277-81. PubMed ID: 6083967
    [Abstract] [Full Text] [Related]

  • 28. [Effect of the endolymphatic administration of protease inhibitors on pancreatic morphofunctional activity in acute experimental pancreatitis].
    Penin VA, Petrov VV, Titova GP, Sil'monovich NN, Shepilova ZhI.
    Farmakol Toksikol; 1982 Dec; 45(5):83-7. PubMed ID: 6183145
    [Abstract] [Full Text] [Related]

  • 29. The kallikrein-kinin system in operated and non-operated patients with acute pancreatitis.
    Hiltunen J, Kaukinen S, Pessi T, Ylitalo P.
    Acta Chir Scand; 1985 Dec; 151(4):371-5. PubMed ID: 3849928
    [Abstract] [Full Text] [Related]

  • 30. Modulation of the proteolytic cascade systems by high dose corticosteroids.
    Aasen AO, Ruud TE, Pillgram-Larsen J, Röise O, Stadaas J.
    Acta Chir Scand Suppl; 1985 Dec; 526():56-65. PubMed ID: 3911708
    [Abstract] [Full Text] [Related]

  • 31. Aprotinin in severe acute pancreatitis.
    Smith M, Kocher HM, Hunt BJ.
    Int J Clin Pract; 2010 Jan; 64(1):84-92. PubMed ID: 19178597
    [Abstract] [Full Text] [Related]

  • 32. A rationale for the therapeutic action of aprotinin.
    Haberland G, McConn R.
    Fed Proc; 1979 Dec; 38(13):2760-7. PubMed ID: 159836
    [Abstract] [Full Text] [Related]

  • 33. [Effect of a polyvalent proteinase inhibitor from the lungs of a bull on the state of the kinin system in burn shock and acute burn toxemia].
    Paskhina TS, Dolgina MI, Nartikova VF, Krinskaia AV, Morozova NA.
    Vopr Med Khim; 1977 Dec; 23(5):689-700. PubMed ID: 339532
    [Abstract] [Full Text] [Related]

  • 34. Studies on the kallikrein-kinin system in plasma and peritoneal fluid during experimental pancreatitis.
    Ruud TE, Aasen AO, Kierulf P, Stadaas J, Aune S.
    Adv Exp Med Biol; 1984 Dec; 167():489-94. PubMed ID: 6561916
    [Abstract] [Full Text] [Related]

  • 35. Effects of protease inhibitor pretreatment on hemodynamic performances and survival rate in experimental, acute pancreatitis.
    Ruud TE, Aasen AO, Pillgram-Larsen J, Stadaas J, Aune S.
    Adv Exp Med Biol; 1986 Dec; 198 Pt B():413-21. PubMed ID: 2433916
    [Abstract] [Full Text] [Related]

  • 36. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
    Gabryelewicz A, Kosidlo S, Prokopowicz J, Podkowicz K.
    Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW.
    Thromb Haemost; 1993 Feb 01; 69(2):141-6. PubMed ID: 7681223
    [Abstract] [Full Text] [Related]

  • 39. Antiproteasic activity of C1 inhibitor. Therapeutic perspectives.
    Cicardi M, Testoni P, Bergamaschini L, Guzzoni S, Cugno M, Buizza M, Bagnolo F.
    Ann Ital Med Int; 1994 Feb 01; 9(3):180-2. PubMed ID: 7524593
    [Abstract] [Full Text] [Related]

  • 40. Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis.
    Lasson A, Ohlsson K.
    Thromb Res; 1986 Jan 15; 41(2):167-83. PubMed ID: 3515616
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.